Micardis/MicardisPlus Monitoring of Morning Hypertension and Metabolism II

Next Previous
Trial Profile

Micardis/MicardisPlus Monitoring of Morning Hypertension and Metabolism II

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2014

At a glance

  • Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
  • Indications Diabetes mellitus; Essential hypertension
  • Focus Therapeutic Use
  • Sponsors Boehringer Ingelheim

    • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 22 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top